Federal record
FDA Warning Letter issued September 9, 2025 · As of September 2026, Vial did not find a close-out letter in FDA records. Read the FDA letter →
We're providing this information based on regulatory filings Vial reviewed as of 2026-09-23. Regulatory status can change, and actions may be resolved or closed out. Confirm current status with the issuing agency: FDA.gov →
Remedy Meds
Reviewed by Vial Editorial · September 27, 2026
Serves 50 states
Is this your company? Claim this profile.
Remedy Meds is a GLP-1 clinic available in all 50 states. The FDA issued a warning letter involving Remedy Meds on September 9, 2025, with no close-out letter found resolving it. Pricing starts at about $299 per month, though total cost should be confirmed before signing up.
What they offerGLP-1 Clinic
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
Remedy Meds scores 38, in the Flagged band. The score moves when the public record changes.
Payment never changes a score.
Score history
- 38September 2026Record updated
- 75August 2026Record updated
- 72July 2026Vial scoring update
- 75June 2026
What we found on Remedy Meds
We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, and LegitScript certification.
Remedy Meds structures its programs around a 365-day money-back guarantee, with compounded semaglutide, tirzepatide, and a microdose plan designed for patients adjusting to GLP-1 treatment. Each compounded batch is disclosed as passing four independent quality tests covering potency, sterility, pH, and endotoxicity. Unlimited clinician video access is included, with same-day appointments available and monthly check-ins built into every plan.
The FDA issued a warning letter involving Remedy Meds on September 9, 2025. We have not found a close-out letter resolving it as of our last check (September 23, 2026); read the details below before going further. The company serves all 50 states. We also confirmed LegitScript certification. Our findings reflect public records reviewed as of September 2026.
Why this score: 5 of 5 checks complete. Each links to the public source it was verified against.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed September 27, 2026.
Our take
Vial EditorialBased on the records and public materials we reviewed.
Remedy Meds is an online clinic selling compounded semaglutide and tirzepatide. The FDA issued a warning letter to Remedy Meds on September 9, 2025. We found no close-out letter for it in FDA records checked on September 23, 2026. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-09092025.
Semaglutide is $179 for the first month, then $299. Tirzepatide is $279, then $399. From our research, they bill every 28 days, which is 13 charges a year: about $3,767 for semaglutide and $5,067 for tirzepatide. They name three medical groups but no individual clinicians, and we couldn't find which pharmacy they use. Trustpilot reviewers give them 4.6 from 13,598 reviews. The Better Business Bureau gives them an F, with 456 complaints in three years, mostly about cancelling, charges and refunds.
What it costs
Remedy Meds lists prices on its medication pages, not its homepage. Compounded semaglutide is $179 for the first month, then $299. Compounded tirzepatide is $279 for the first month, then $399. The company states the price does not rise when your dose goes up. The fee covers the prescription, clinician visits by video or chat, dose changes, and 48-hour cold shipping. We saw no lab work listed as included or required. The terms describe 13 shipments in a year, one every 28 days, while the medication pages quote prices per month. So a first year of semaglutide is $179 plus 12 charges of $299, or $3,767. Tirzepatide is $279 plus 12 charges of $399, or $5,067. The terms also allow the next charge or shipment to run up to 10 days early. The terms mention 3, 6 and 12 month bundles. We could not find those prices without taking the quiz. The site also sells a GLP-1 microdose plan and brand-name Ozempic and Zepbound. One third-party site quotes about $189 for the microdose plan and about $1,299 to $1,399 for the brand-name drugs, figures we could not confirm. You must cancel at least 48 hours before your term ends, or it renews. Once paid, the fee is non-refundable, except if a clinician turns you down or you qualify for the 365-day weight-loss offer. That offer applies to month-to-month plans only. The company states it is HSA and FSA eligible. It does not take insurance. Before paying, get in writing the exact date and amount of your next charge, and how to stop it.
Sources: remedymeds.com · remedymeds.com · remedymeds.com · remedymeds.com · accessnewswire.com · healthypound.com · ozarihealth.com
What patients report
On Trustpilot, Remedy Meds shows 4.6 out of 5 from 13,598 reviews, seen September 21, 2026. About 86% are 5-star and 6% are 1-star. Trustpilot reports the company replies to about 99% of negative reviews, usually within a day. Praise centers on nurses and clinicians who take time on the video visit and on prescriptions that move quickly after the call. The BBB picture is very different. Seen the same day, the BBB gives Remedy Meds an F and it is not accredited. The BBB counts 456 complaints in three years and 375 closed in the last 12 months. Of those, 22 are listed as not resolved and 11 as unanswered. The newest complaint we saw was dated August 1, 2026. The largest groups are product issues (196), service issues (114) and billing (50). Common themes are charges that kept coming after people tried to cancel, refund requests that were refused, late or lost shipments, and no way to pause a plan. The pattern is that the medical visit tends to go well, and the trouble starts with billing and stopping the plan. We did not find a usable Reddit thread.
Sources: trustpilot.com · bbb.org · bbb.org
What the record means
Vial scores Remedy Meds 38 out of 100, Flagged.
The FDA issued a warning letter to Remedy Meds on September 9, 2025. We found no close-out letter for it in FDA records checked on September 16, 2026. The letter is published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-09092025. The company displays a LegitScript seal, and our record lists it as certified. The company states it serves all 50 states plus Washington, D.C. States served have not been checked. The company states its medication comes from licensed U.S. 503A compounding pharmacies and that each batch is tested before shipping. No pharmacy partner is named, so you cannot look up who compounds the medication. The company states that care is delivered through outside medical groups, naming OpenLoop Healthcare Partners, JMP Medical and KMG Medical Group. Individual clinicians are not identified on the company's site. You can ask which pharmacy will fill your order and look up its license with your state board before you pay.
Worth asking before you choose
Ask these before you sign up.
- 1What changed after the FDA warning letter?
- 2Has FDA issued a close-out letter?
- 3Are you operating as a 503A pharmacy or a 503B outsourcing facility?
- 4Which states are you licensed to ship to?
- 5Can you provide current state pharmacy license details?
See all 5 questionsShow fewer
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
Absolutely Thin has no federal action found; Remedy Meds has an FDA warning letter with no close-out letter found.
Remedy Meds scores 38, Absolutely Thin scores 77.
Remedy Meds holds LegitScript certification; Absolutely Thin does not.
| Remedy Meds | Absolutely Thin | |
|---|---|---|
| Federal actions | Confirmed | None found |
| Vial Score | 38/100 | 77/100 |
| LegitScript certified | Yes | No |
| States served | Nationwide (50 states) | Nationwide (50 states) |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Treatments offered
Other GLP-1 providers in Vial
Other GLP-1 clinics in Vial’s directory. Open a profile, or compare side by side.
See 2 more alternativesShow fewer
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerMore GLP-1 providers
Appears on: Tirzepatide Cost in 2026
Appears on: Semaglutide Cost in 2026
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.